NPI: 1205366416 · INDIANAPOLIS, IN 46202 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/20/2017
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 06/20/2017 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,355 | $90K |
| 2019 | 23,446 | $155K |
| 2020 | 28,050 | $296K |
| 2021 | 19,331 | $247K |
| 2022 | 17,289 | $286K |
| 2023 | 5,181 | $176K |
| 2024 | 3,670 | $161K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 52,299 | 3,046 | $1.32M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 31,975 | 1,179 | $37K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 570 | 227 | $30K |
| J1756 | Injection, iron sucrose, 1 mg | 6,034 | 964 | $16K |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,474 | 1,210 | $5K |
| 83970 | 1,153 | 725 | $160.85 | |
| A4657 | Syringe, with or without needle, each | 4,211 | 1,224 | $124.15 |
| 82728 | 698 | 466 | $35.53 | |
| 90674 | 62 | 35 | $27.38 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 120 | 56 | $22.68 |
| 83550 | 699 | 452 | $17.03 | |
| 83540 | 697 | 452 | $12.61 | |
| 85041 | 1,302 | 819 | $11.05 | |
| 85048 | 1,298 | 819 | $9.28 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 172 | 94 | $6.47 |
| 82108 | 117 | 76 | $5.83 | |
| 85045 | 357 | 206 | $4.13 | |
| G0008 | Administration of influenza virus vaccine | 84 | 46 | $0.00 |